DXCM Trading Analysis - 09/11/2026 03:06 PM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for DXCM include:

• DXCM has been in focus due to its role in the continuous glucose monitoring (CGM) market, with growing competition from other medical device companies.
• The company has seen increased adoption of its CGM systems, which could positively impact revenue growth.
• There have been concerns about the impact of regulatory changes on the medical device industry, which could affect DXCM's business operations.

These headlines suggest that DXCM is operating in a dynamic and competitive environment, with both opportunities and challenges that could impact its stock performance.

Fundamental Analysis:

Based on the provided fundamentals data:

• Revenue: $4,969,200,000
• Trailing EPS: $2.52
• Trailing P/E: 33.54
• Price-to-Book: 25.69
• Debt-to-Equity: 1.46
• Return on Equity (ROE): 38.14%
• Gross Margin: 62.47%
• Operating Margin: 22.92%
• Profit Margin: 20.12%

The company's fundamentals indicate a strong revenue base, with a high profit margin and ROE. However, the P/E ratio and debt-to-equity ratio may be considered high by some investors.

Current Market Position:

Current price: $83.05

Recent price action: The stock has been trading in a range, with a recent low of $82.89 and a high of $85.82.

Intraday momentum and trends: The minute bars show a relatively stable price action in the recent sessions.

Technical Analysis:

SMA trends: The 5-day SMA is $84.77, the 20-day SMA is $88.72, and the 50-day SMA is $82.42.

RSI interpretation: The RSI is currently at 18.59, indicating that the stock may be oversold.

MACD signals: The MACD line is above the signal line, indicating a bullish signal.

Bollinger Bands: The stock price is currently near the lower band, indicating potential support.

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment: Balanced

Call vs Put dollar volume analysis: Call dollar volume is $831,945, and put dollar volume is $1,090,930.

Pure directional positioning suggests a neutral near-term expectation.

Key Price Levels (observational only):

25-Day Price Forecast:

DXCM is projected for $80.00 to $90.00

Based on current technical trends, momentum, and indicators, the stock price is expected to trade within this range.

Defined Risk Strategy Recommendations:

Based on the price forecast, here are three defined risk strategy recommendations:

• Bull Call Spread: Buy the $85.00 call and sell the $90.00 call, expiring on 2026-10-16.
• Bear Put Spread: Buy the $80.00 put and sell the $75.00 put, expiring on 2026-10-16.
• Iron Condor: Sell the $82.50 put, buy the $75.00 put, sell the $87.50 call, and buy the $90.00 call, expiring on 2026-10-16.

These strategies align with the projected price range and offer a balanced risk-reward profile.

Risk Factors:

• Technical warning signs: The RSI indicates that the stock may be oversold.
• Sentiment divergences: The options flow sentiment is balanced, indicating a neutral near-term expectation.
• Volatility and ATR considerations: The ATR is $2.38, indicating moderate volatility.

These risk factors should be considered when implementing the recommended strategies.

Summary & Conviction Level:

Overall bias: Neutral

Conviction level: Medium

One-line trade idea: Consider a bull call spread or iron condor strategy to capitalize on the expected trading range.